CervoMed IncCRVO
Price$2.93Intrinsic value$4.8164% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $331.3K-96.6% YoYTTM through 30 Jun 2026
Net Income -$30.3MTTM through 30 Jun 2026
Free Cash Flow -$28MTTM through 30 Jun 2026

Margins

Current
Gross Margin0.0%
Operating Margin-9,407.0%
Net Margin-9,160.9%

Returns

-282.8%ROE
-198.8%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio3.36x
Net Debt-$12.9Mnet cash position
Cash & Equivalents$22.5M

Quality Metrics

Altman Z-Score-1.43
Piotroski F-Score2 / 9
FCF Margin-8,444.9%
Earnings-Beat Rate0.0%

Multi-Year Trend

Revenue
'11'12'22'23'24'25
FY2025: $4M
Diluted EPS
'16'17'18'22'23'24'25
FY2025: $-2.98

Dividend

No dividend

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.